Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 2/20 | 0.60 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL4458630 | 1.00 | CA5A (0.60) | CA5ACA5BTSHRMEN1ALDH1A1 | |
| Sulfuric Acid SCHEMBL4458576 | 0.95 | CA5A (0.55) | CA5ACA5BTSHRMEN1ALDH1A1 | |
| Sulfuric Acid SCHEMBL27878972 | 0.95 | CA5A (0.67) | CA5ACA5BTSHRMEN1ALDH1A1 | |
| Sulfuric Acid SCHEMBL10705876 | 0.90 | CA5A (0.60) | CA5ACA5BTSHRMEN1ALDH1A1 | |
| Sulfuric Acid SCHEMBL22654575 | 0.90 | CA5A (0.60) | CA5ACA5BTSHRMEN1ALDH1A1 | |
| Sulfuric Acid SCHEMBL2779397 | 0.90 | TSHR (0.73) | CA5ACA5BTSHRMEN1ALDH1A1 | |
| Sulfuric Acid SCHEMBL20597916 | 0.90 | CA5A (0.60) | CA5ACA5BTSHRMEN1ALDH1A1 | |
| Sulfuric Acid SCHEMBL21292077 | 0.90 | CA5A (0.60) | CA5ACA5BTSHRMEN1ALDH1A1 | |
| Sulfuric Acid SCHEMBL16754230 | 0.90 | CA5A (0.60) | CA5ACA5BTSHRMEN1ALDH1A1 | |
| Sulfuric Acid SCHEMBL10179353 | 0.90 | CA5A (0.60) | CA5ACA5BTSHRMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-8092272-A | — | — | None | — | — | JP | disclosed |
| JP-8259585-A | — | — | None | — | — | JP | disclosed |
| JP-5255366-A | — | — | None | — | — | JP | disclosed |
| JP-5117286-A | — | — | None | — | — | JP | disclosed |
| US-20090131726-A1 | Method of Making Mixed Metal Oxide Containing Sulfur | EXXONMOBIL CHEMICAL PATENTS INC. | 2009-05-21 | — | — | US | disclosed |
| US-7468465-B2 | Decomposition of isopropyl ether using cerium-zirconium oxide catalyst in the presence of water (acidic mixed metal oxideXmYnSpOq, wherein X is metal selected from Group 4 , Y metal selected from Group 3 ) to produce isopropyl alcohol | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-12-23 | — | — | US | disclosed |
| EP-1893334-A1 | MIXED METAL OXIDE CONTAINING SULFUR | Exxonmobil Chemical Patents Inc. (US) | 2008-03-05 | — | — | EP | disclosed |
| EP-1893333-A1 | METHOD OF MAKING MIXED METAL OXIDE CONTAINING SULFUR | ExxonMobil Chemical Patents Inc. (US) | 2008-03-05 | — | — | EP | disclosed |
| US-7282192-B2 | Mixed metal oxide containing sulfur | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-10-16 | — | — | US | disclosed |
| US-20070123740-A1 | Mixed metal oxide containing sulfur | VARTULI JAMES C | 2007-05-31 | — | — | US | disclosed |
| EP-0657412-B1 | SAINTOPIN DERIVATIVE | KYOWA HAKKO KOGYO KK (JP) | 1998-02-04 | — | — | EP | disclosed |
| JP-H08259585-A | PHYSIOLOGICALLY ACTIVE SUBSTANCE FR 183783 | FUJISAWA PHARMACEUT CO LTD | 1996-10-08 | — | — | JP | disclosed |
| US-5510501-A | ANTIBACTERIAL AND ANTITUMOR ACTIVITY | KYOWA HAKKO KOGYO, CO. LTD. (JP) | 1996-04-23 | — | — | US | disclosed |
| JP-H0892272-A | THERAPEUTIC SUBSTANCE FR177391 FOR CANCER CACHEXY | FUJISAWA PHARMACEUT CO LTD | 1996-04-09 | — | — | JP | disclosed |
| EP-0657412-A1 | SAINTOPIN DERIVATIVE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1995-06-14 | — | — | EP | disclosed |
| JP-H05255366-A | NEW ARTERIALIZATION INHIBITING SUBSTANCE FR901484 | FUJISAWA PHARMACEUT CO LTD | 1993-10-05 | — | — | JP | disclosed |
| JP-H05117286-A | WS80,130 SUBSTANCE, ITS PRODUCTION AND USE | FUJISAWA PHARMACEUT CO LTD | 1993-05-14 | — | — | JP | disclosed |
| US-5187195-A | Vasodilators; endothelin agonists; 1,7,12-trioxo,3-methyl, 4a,8,12a,12b-tetrahydroxy,6a-(2-amino-2-acylethylthio)-1,4, 4a,5,6,6a,7,12,12a,12b-decahydroanthroquinones | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-16 | — | — | US | disclosed |
| EP-0405421-A2 | Anthraquinone derivatives and preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-01-02 | — | — | EP | disclosed |
| JP-H00892272-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123740-A1 | Mixed metal oxide containing sulfur | SOD1, SOD3, AP3M1 | CA5A 1712/4885CA5B 1247/4885TSHR 4842/4885 |
| US-20090131726-A1 | Method of Making Mixed Metal Oxide Containing Sulfur | IKZF3, ICMT, ITPA | CA5A 689/4885CA5B 724/4885TSHR 3297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.